This Article  • Full text  • PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Citing articles on ISI (207)  • Contact me when this article is cited  Related Content  • Related article  • Similar articles in JAMA  Topic Collections  • Randomized Controlled Trial  • Alert me on articles by topic  Social Bookmarking   What's this?

A Randomized Controlled Efficacy Trial

Edward P. Sloan, MD, MPH; Max Koenigsberg, MD; David Gens, MD; Mark Cipolle, MD, PhD; Jeffrey Runge, MD; Mary Nan Mallory, MD; George Rodman, Jr, MD; for the DCLHb Traumatic Hemorrhagic Shock Study Group

JAMA. 1999;282:1857-1864.

Context  Severe, uncompensated, traumatic hemorrhagic shock causes significant morbidity and mortality, but resuscitation with an oxygen-carrying fluid might improve patient outcomes.

Objective  To determine if the infusion of up to 1000 mL of diaspirin cross-linked hemoglobin (DCLHb) during the initial hospital resuscitation could reduce 28-day mortality in traumatic hemorrhagic shock patients.

Design and Setting  Multicenter, randomized, controlled, single-blinded efficacy trial conducted between February 1997 and January 1998 at 18 US trauma centers selected for their high volume of critically injured trauma patients, but 1 did not enroll patients.

Patients  A total of 112 patients with traumatic hemorrhagic shock and unstable vital signs or a critical base deficit, who had a mean (SD) patient age of 39 (20) years. Of the infused patients, 79% were male and 56% were white. An exception to informed consent was used when necessary.

Intervention  All patients were to be infused with 500 mL of DCLHb or saline solution. Critically ill patients who still met entry criteria could have received up to an additional 500 mL during the 1-hour infusion period.

Main Outcome Measures  Twenty-eight day mortality, 28-day morbidity, 48-hour mortality, and 24-hour lactate levels.

Results  Of the 112 patients, 98 (88%) were infused with DCLHb or saline solution. At 28 days, 24 (46%) of the 52 patients infused with DCLHb died, and 8 (17%) of the 46 patients infused with the saline solution died (P = .003). At 48 hours, 20 (38%) of the 52 patients infused with DCLHb died and 7 (15%) of the 46 patients infused with the saline solution died (P = .01). The 28-day morbidity rate, as measured by the multiple organ dysfunction score, was 72% higher in the DCLHb group (P = .03). There was no difference in adverse event rates or the 24-hour lactate levels.

Conclusions  Mortality was higher for patients treated with DCLHb. Although further analysis should investigate whether the mortality difference was solely due to a direct treatment effect or to other factors, DCLHb does not appear to be an effective resuscitation fluid.

Author Affiliations: Department of Emergency Medicine, University of Illinois at Chicago, Chicago (Drs Sloan and Koenigsberg); University of Maryland, Shock Trauma Center, Baltimore (Dr Gens); Lehigh Valley Hospital, Allentown, Pa (Dr Cipolle); Carolinas Medical Center, Charlotte, NC (Dr Runge); University of Louisville Hospital, Louisville, Ky (Dr Mallory); and Methodist Hospital of Indiana, Indianapolis (Dr Rodman). Study group investigators are listed below.

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati     What's this?

RELATED ARTICLE

November 17, 1999
JAMA. 1999;282(19):1885-1886.
EXTRACT | FULL TEXT  

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Erythrocyte Hemolysis and Hemoglobin Oxidation Promote Ferric Chloride-induced Vascular Injury
Woollard et al.
J. Biol. Chem. 2009;284:13110-13118.
ABSTRACT | FULL TEXT  

Hemoglobin-Based Blood Substitutes and Risk of Myocardial Infarction and Death
Lewis and Fost
JAMA 2008;300:1296-1296.
FULL TEXT  

Hemoglobin-Based Blood Substitutes and Risk of Myocardial Infarction and Death--Reply
Natanson et al.
JAMA 2008;300:1298-1299.
FULL TEXT  

Fluids as oxygen carriers and the potential role in trauma resuscitation
Shirley
Trauma 2008;10:139-147.
ABSTRACT  

The Future of Clinical Trials Evaluating Blood Substitutes
Fergusson and McIntyre
JAMA 2008;299:2324-2326.
FULL TEXT  

Cell-Free Hemoglobin-Based Blood Substitutes and Risk of Myocardial Infarction and Death: A Meta-analysis
Natanson et al.
JAMA 2008;299:2304-2312.
ABSTRACT | FULL TEXT  

Encapsulation of Concentrated Hemoglobin Solution in Phospholipid Vesicles Retards the Reaction with NO, but Not CO, by Intracellular Diffusion Barrier
Sakai et al.
J. Biol. Chem. 2008;283:1508-1517.
ABSTRACT | FULL TEXT  

Blood conservation strategies to reduce the need for red blood cell transfusion in critically ill patients
Tinmouth et al.
CMAJ 2008;178:49-57.
ABSTRACT | FULL TEXT  

Evolution of adverse changes in stored RBCs
Bennett-Guerrero et al.
Proc. Natl. Acad. Sci. USA 2007;104:17063-17068.
ABSTRACT | FULL TEXT  

Effects of Endogenous Ascorbate on Oxidation, Oxygenation, and Toxicokinetics of Cell-Free Modified Hemoglobin after Exchange Transfusion in Rat and Guinea Pig
Buehler et al.
J. Pharmacol. Exp. Ther. 2007;323:49-60.
ABSTRACT | FULL TEXT  

Salvage of focal cerebral ischemic damage by transfusion of high O2-affinity recombinant hemoglobin polymers in mouse
Nemoto et al.
J. Appl. Physiol. 2006;100:1688-1691.
ABSTRACT | FULL TEXT  

Resuscitation fluids in trauma, part II: which fluid should I give?
Vercueil et al.
Trauma 2006;8:111-121.
 

Intensive care and emergency medicine: progress over the past 25 years.
Vincent et al.
Chest 2006;129:1061-1067.
ABSTRACT | FULL TEXT  

Natural resistance, iron and infection: a challenge for clinical medicine.
Bullen et al.
J Med Microbiol 2006;55:251-258.
ABSTRACT | FULL TEXT  

Nitric Oxide Scavenging by Red Blood Cells as a Function of Hematocrit and Oxygenation
Azarov et al.
J. Biol. Chem. 2005;280:39024-39032.
ABSTRACT | FULL TEXT  

The Clinical Sequelae of Intravascular Hemolysis and Extracellular Plasma Hemoglobin: A Novel Mechanism of Human Disease
Rother et al.
JAMA 2005;293:1653-1662.
ABSTRACT | FULL TEXT  

Comparison of PEG-modified albumin and hemoglobin in extreme hemodilution in the rat
Winslow et al.
J. Appl. Physiol. 2004;97:1527-1534.
ABSTRACT | FULL TEXT  

Evidence-Based Medicine in the ICU: Important Advances and Limitations
Vincent
Chest 2004;126:592-600.
ABSTRACT | FULL TEXT  

Increased Cerebral Tissue Oxygen Tension After Extensive Hemodilution with a Hemoglobin-Based Oxygen Carrier
Hare et al.
Anesth. Analg. 2004;99:528-535.
ABSTRACT | FULL TEXT  

Hemodynamic response and oxygen transport in pigs resuscitated with maleimide-polyethylene glycol-modified hemoglobin (MP4)
Drobin et al.
J. Appl. Physiol. 2004;96:1843-1853.
ABSTRACT | FULL TEXT  

NO Contest: Nitrite Versus S-Nitroso-Hemoglobin
Gladwin and Schechter
Circ. Res. 2004;94:851-855.
FULL TEXT  

A Modified Poisson Regression Approach to Prospective Studies with Binary Data
Zou
Am J Epidemiol 2004;159:702-706.
ABSTRACT | FULL TEXT  

The Safety of Hemoglobin Blood Substitutes * Response
Bloomfield et al.
Anesth. Analg. 2004;98:1193-1193.
FULL TEXT  

Differential effects of sodium selenite in reducing tissue damage caused by three hemoglobin-based oxygen carriers
Baldwin et al.
J. Appl. Physiol. 2004;96:893-903.
ABSTRACT | FULL TEXT  

Measurements of nitric oxide on the heme iron and {beta}-93 thiol of human hemoglobin during cycles of oxygenation and deoxygenation
Xu et al.
Proc. Natl. Acad. Sci. USA 2003;100:11303-11308.
ABSTRACT | FULL TEXT  

Diaspirin-Crosslinked Hemoglobin Reduces Blood Transfusion in Noncardiac Surgery: A Multicenter, Randomized, Controlled, Double-Blinded Trial
Schubert et al.
Anesth. Analg. 2003;97:323-332.
ABSTRACT | FULL TEXT  

Comparison of effects of two hemoglobin-based O2 carriers on intestinal integrity and microvascular leakage
Baldwin et al.
Am. J. Physiol. Heart Circ. Physiol. 2002;283:H1292-H1301.
ABSTRACT | FULL TEXT  

Polymerized bovine hemoglobin solution as a replacement for allogeneic red blood cell transfusion after cardiac surgery: Results of a randomized, double-blind trial
Levy et al.
J. Thorac. Cardiovasc. Surg. 2002;124:35-42.
ABSTRACT | FULL TEXT  

Comparison of transfusion with DCLHb or pRBCs for treatment of intraoperative anemia in sheep
Vane et al.
J. Appl. Physiol. 2002;92:343-353.
ABSTRACT | FULL TEXT  

Redox cycling of diaspirin cross-linked hemoglobin induces G2/M arrest and apoptosis in cultured endothelial cells
D'Agnillo and Alayash
Blood 2001;98:3315-3323.
ABSTRACT | FULL TEXT  

Hemoglobin-Vesicles as Oxygen Carriers : Influence on Phagocytic Activity and Histopathological Changes in Reticuloendothelial System
Sakai et al.
Am. J. Pathol. 2001;159:1079-1088.
ABSTRACT | FULL TEXT  

Safeguarding Patients in Clinical Trials with High Mortality Rates
FREEMAN et al.
Am. J. Respir. Crit. Care Med. 2001;164:190-192.
FULL TEXT  

Which fluid to give?
Protheroe and Nolan
Trauma 2001;3:151-160.
ABSTRACT  

Effects of Diaspirin Cross-Linked Hemoglobin (DCLHb) during and Post-CPR in Swine
Chow et al.
J. Pharmacol. Exp. Ther. 2001;297:224-229.
ABSTRACT | FULL TEXT  

Physiological Properties of Blood Substitutes
Spahn and Pasch
Physiology 2001;16:38-41.
ABSTRACT | FULL TEXT  

Hemoglobin and Methemoglobin Concentrations After Large-Dose Infusions of Diaspirin Cross-Linked Hemoglobin
O'Hara et al.
Anesth. Analg. 2001;92:44-48.
ABSTRACT | FULL TEXT  

Interactions of hemoglobin with hydrogen peroxide alters thiol levels and course of endothelial cell death
D'Agnillo and Alayash
Am. J. Physiol. Heart Circ. Physiol. 2000;279:H1880-H1889.
ABSTRACT | FULL TEXT  

The Prospects for Red-Cell Substitutes
Klein
NEJM 2000;342:1666-1668.
FULL TEXT  

Hemoglobin Solution Not of Benefit in Traumatic Shock
JWatch Emergency Med. 2000;2000:18-18.
FULL TEXT  

Impact of New Technologies in Medicine: A Global Theme Issue
Mark and Glass
JAMA 1999;282:1875-1875.
FULL TEXT  

Regional cerebral blood flow in cats with cross-linked hemoglobin transfusion during focal cerebral ischemia
Rebel et al.
Am. J. Physiol. Heart Circ. Physiol. 2002;282:H832-H841.
ABSTRACT | FULL TEXT